SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001144204-17-008931
Filing Date
2017-02-14
Accepted
2017-02-14 17:01:44
Documents
1
Group Members
FRED KNOLLGAKASA HOLDINGS, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A v459595_sc13ga.htm SC 13G/A 87622
  Complete submission text file 0001144204-17-008931.txt   89318
Mailing Address 5 EAST 44TH STREET 12TH FLOOR NEW YORK NY 10017
Business Address 5 EAST 44TH STREET 12TH FLOOR NEW YORK NY 10017 212-808-7474
Knoll Capital Management, LP (Filed by) CIK: 0001325083 (see all company filings)

IRS No.: 133476926 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Subject) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-86512 | Film No.: 17610063
SIC: 2834 Pharmaceutical Preparations